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Lymphocytic mastopathy or diabetic mastopathy is a benign breast disease characterized by dense ﬁbrosis, lobular atrophy, and
aggregates of lymphocytes in a periductal and perilobular distribution. The condition usually aﬀects women with a long history
of diabetes mellitus (DM) and also those with autoimmune disorders. While the pathogenesis is unknown, a particular type of
class II human leukocyte antigen has been associated with this disease. Herein, we report a case of diabetic mastopathy which
clinically and radiologically mimicked primary breast neoplasms. The patient was a 74-year-old woman with a 31-year history
of DM type II who presented with multiple ﬁrm lumps in bilateral breasts. Findings from mammography, ultrasonography,
and magnetic resonance imaging of the breasts revealed an abnormal appearance which suspiciously resembled malignancy. An
aspiration cytology specimen showed atypical accumulation of lymphoid cells, leading us to suspect lymphoma. Histology of
an excisional biopsy showed the characteristic appearance of lymphocytic mastopathy, which predominantly consisted of B-
lymphocytes.Autoantibodiesinherserumreactedpositivelyagainstherductalepitheliumaswellasotherdiabeticandnondiabetic
breast ductal cells. An antigen absorption test with insulin revealed attenuating intensity according to insulin concentration. These
anti-insulin antibodies produced in the DM patient may cause ductitis because of antigen cross-reactivity.
1.Introduction
Diabetic mastopathy, also known as lymphocytic mastitis
or lymphocytic mastopathy, is occasionally seen in women
who have longstanding diabetes mellitus (DM). The typical
presentation is suspicious ﬁbrous breast lumps. Pathology
reveals dense keloid-like ﬁbrosis and periductal, lobular, or
perivascularlymphocyticinﬁltration[1,2].Whilethedisease
pathogenesis is unknown, the condition may be the result of
an autoimmune reaction since the histological features are
similar to those seen in other autoimmune diseases [3]. Here
we present a case of diabetic mastopathy, which proposes the
pathogenetic hypothesis that autoantibodies against insulin
may cause autoimmune mastitis because of cross-reactivity
to mammary ducts.
2. CaseStudy
A 74-year-old woman complained of a right breast mass
which had appeared four years earlier. She had a 31-year
history of DM with insulin treatment.
Upon palpation, two hard lumps in the right breast were
discovered (Figure 1, right breast). One tumor had a maxi-
mum diameter of 45mm with a clear margin over the CAE
area, and the other was 25mm in diameter with a clear
margin in the A area 25mm from the nipple. No growths
were palpated in the left breast, and surface lymph node
swelling was not present.
A mediolateral oblique and craniocaudal mammo-
graphic view of the right breast demonstrated a dense
microlobulated mass 16 × 21mm in size with a small round2 Case Reports in Medicine
Figure 1: Three separate tumors of the breast by palpation and
imaging,twohardtumorsintheCDAandAareasoftherightbreast
andonenonpalpablesolidtumorintheCareaoftheleftbreastwere
found.
Figure 2: Magnetic resonance imaging of the breast dense
microlobulated masses with irregular margins, 43 × 52 × 37mm
and 17 × 23 × 14mm, were seen in the CDA and A areas of the
right breast, respectively. In the C area of the left breast, a similar
characteristic mass, 11 × 20 × 15mm, was also seen.
Figure 3: Macroscopic cut sections of the tumor A well-deﬁned
elastic hard mass, 2.5 × 2 × 1cm, was excised from the A area of
the right breast. Meshwork composed of whitish ﬁbers separating
atrophic fatty breast tissue was observed.
Figure 4: Histology of the breast tumor (×40). Many small
lymphocytes inﬁltrated periducts with surrounding dense collagen
ﬁbers, accompanied by lymph follicles with germinal centers.
Figure 5: High magniﬁcation of the tumor (×400). Small lympho-
cytes inﬁltrated between ductal epithelia forming lymphoepithelial
lesions.
calciﬁcation in the MI area 43mm from the nipple. Abnor-
mality including carcinoma was suspected. The left breast
showed no remarkable changes.
Ultrasonography revealed an ill-deﬁned, irregular-
shaped hypoechoic area with acoustic shadowing at the 9-to
12-o’clock position of the right breast. At the 2-o’clock
position in A area 25mm from the nipple, a well-deﬁned
hypoechoic mass with posterior acoustic shadowing was
seen. At the 2.5-o’clock position 25mm from the nipple of
the left breast, an ill-deﬁned, irregular-shaped hypoechoic
area with acoustic shadowing was seen (Figure 1, left breast).
These masses did not exclude the possibility of carcinoma.
Dense microlobulated masses with irregular margins,
43 × 52 × 37mm and 17 × 23 × 14mm, were revealed by
magnetic resonance imaging (Figure 2), in the CDA and A
areas of the right breast, respectively. In the C area of the left
breast, a similar characteristic mass, 11 × 20 × 15mm, was
also seen.
Afewclustersofductalcellsandmanysmalllymphocytes
were present in an aspiration cytology specimen, which
suggested malignant lymphoma.Case Reports in Medicine 3
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Figure 6: Lymphocyte markers by immunostaining. Inﬁltrating lymphocytes consisted more of CD20-positive cells than CD3-positive cells.
IgG4-positive lymphocytes were rarely found compared with IgG positive cells.
A well-deﬁned elastic hard mass from the A area of the
rightbreastwasremovedbecauseofsuspicionofmalignancy.
Cutsectionsrevealedameshworkcomposedofwhitishﬁbers
separating atrophic fatty breast tissue (Figure 3).
Histology revealed lymphocytic ductitis or lobulitis with
surrounding dense ﬁbrosis (Figure 4).
Smalllymphocyteshadinﬁltratedbetweenductalepithe-
lia forming lymphoepithelial lesions (Figure 5). These lym-
phocytes comprised more of CD20-positive cells (Figure 6)
than sparse CD3-positive cells. IgG4-positive lymphocytes
were rarely found compared with IgG-positive cells.
On investigating the pathogenesis of this disease, autoan-
tibodies against breast tissues were detected by an indirect
immunoperoxidase technique using the patient’s serum as
the primary antibody [4]. The endogenous peroxidase was
inactivated by dipping sections in 0.3% hydrogen peroxide
and 0.1% sodium azide for 10min. The sections were then
washed in phosphate buﬀered saline (PBS) three times and
soaked with 30% normal rabbit serum in PBS for 10min
to avoid nonspeciﬁc absorption. The patient’s serum was
applied as the primary antibody at serial concentrations of
1:50, 1:100, 1:200, 1:400, and 1:800. Normal human
serum was used as a negative staining control. Incubation
was at 4◦Co rr o o mt e m p e r a t u r ef o r1 . 5 h .A f t e rw a s h i n g
threetimes inPBS,sections wereincubatedwithanti-human
IgG, IgM, IgA, kappa, and lambda antibodies labeled with
horseradish peroxidase (DAKO, Kyoto, Japan) at a 1:50
dilution for 30min. After washing three more times in
PBS, sections were stained with diaminobenzidine-hydrogen
peroxide solution.
The antigen absorption method was performed by mix-
ing patient serum with human recombinant insulin (Invit-
rogen, Carlsbad, CA, USA) for 1h at room temperature
and 1.5h at 4◦C followed by centrifugation. The insulin
concentration was increased stepwise from 40ng/mL to
400µg/mL 10 times. Bovine albumin was used as a negative
control.
Using the patient’s serum as a primary antibody resulted
in positive staining of ductal epithelia at dilutions of
1:100 to 1:200 (Figure 7(a)). Ductal epithelia from other
diabetic (Figure 7(b)) or nondiabetic patients (Figure 7(c))
also showed a positive reaction.
The antibody absorption test with insulin showed atten-
uating staining intensity corresponding to increasing insulin
concentrations. At 40ng/mL, positive staining of ductal
epithelia remained (Figure 8(a)), while at 4µg/mL, staining
intensity decreased signiﬁcantly (Figure 8(b))a n da l m o s t
disappeared at 40µg/mL (Figure 8(c)).4 Case Reports in Medicine
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Figure 7: Autoantibody reacting to the patient’s own (a), other
DM patient’s (b), and non-DM patient’s (c) breast tissue. Using the
patient’s serum as the primary antibody, ductal epithelium showed
positive staining at a 1:200 dilution.
3. Discussion
An association between DM and ﬁbrous breast disease
was reported initially in 1984 by Soler and Khardori
[1] who described 12 patients with longstanding type 1
DM, multiple diabetic complications, and palpable breast
masses. Three years later, the term diabetic mastopathy
was coined for the characteristic combination of connective
tissue overgrowth with perivascular lymphocytic inﬁltration
of the lesion. As similar histopathological features were
observedinpatientswithautoimmunedisease,andincreased
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Figure 8: Antibody absorption test with insulin added to the
primary serum at 40ng/mL (a), 4µg/mL (b), and 40µg/mL (c).
Staining intensity attenuated corresponding to insulin concentra-
tion. At 40ng/mL, positive staining of ductal epithelia remained,
while at 4µg/mL, staining intensity decreased signiﬁcantly and
almost disappeared at 40µg/mL.
human leukocyte antigen-DR expression by breast epithelial
cells was observed, the hypothesis that this disease was a
connective tissue disorder or an autoimmune disorder was
raised [3]. B-cell-predominant lymphoid inﬁltrates forming
lymphoepithelial lesions were present [5] as seen in this
case; however, the B cells were polyclonal and the risk for
lymphoma is low in diabetic mastopathy.Case Reports in Medicine 5
Lymphoplasmacytic inﬁltration with ﬁbrosis reminded
us of the recently proposed entity, IgG4-related sclerosing
disease, which has been found in the whole body [6, 7]. Zen
et al. reported an inﬂammatory pseudotumor of the breast
associated with this sclerosing disease [7]. Since the present
case showed little plasma cell inﬁltration and rare IgG4-
positive plasma cells in the lesion, the possibility of IgG4-
related sclerosing mastitis is very low.
The autoantibody against insulin and breast ductal cells
indicates that there may be a connection to feeding cow
milk. There are some reports which indicate that short-
term exclusive breastfeeding or early exposure to cow milk
formulas can increase the risk of type 1 DM [8, 9]. Cow milk
contains bovine insulin [8] and possibly breast ductal cell
components. Autoantibodies to insulin, GAD65, and protein
tyrosine phosphatase-related IA-2 molecules were induced
more in infants who had been exclusively breastfed for
less than two months than those who had been exclusively
breastfed for at least four months [9].
Molecular mimicry is characterized by an immune re-
sponse to an environmental agent that cross-reacts with a
host antigen, resulting in disease. This pathogenesis has been
implicated in the pathogenesis of diabetes [10].
Inconclusion,thisistheﬁrstpaperofadiabeticmastopa-
thy patient having autoantibodies against insulin and ductal
cells with cross-reactivity.
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